These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1603880)

  • 41. [Neuroendocrine disturbances observed in obsessive compulsive disorders].
    Hantouche E; Olié JP
    Ann Med Psychol (Paris); 1992; 150(2-3):152-7. PubMed ID: 1343510
    [No Abstract]   [Full Text] [Related]  

  • 42. The neuroethological approach to obsessive-compulsive disorder.
    Stein DJ; Shoulberg N; Helton K; Hollander E
    Compr Psychiatry; 1992; 33(4):274-81. PubMed ID: 1643870
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The anterior pituitary responds normally to protirelin in obsessive-compulsive disorder: evidence to support a neuroendocrine serotonergic deficit.
    Lucey JV; Butcher G; Clare AW; Dinan TG
    Acta Psychiatr Scand; 1993 Jun; 87(6):384-8. PubMed ID: 8356888
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The psychopharmacology of obsessive compulsive disorder. Implications for treatment and pathogenesis.
    McDougle CJ; Goodman WK; Leckman JF; Price LH
    Psychiatr Clin North Am; 1993 Dec; 16(4):749-66. PubMed ID: 8309811
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Obsessive-compulsive disorder and serotonin: is there a connection?
    Insel TR; Mueller EA; Alterman I; Linnoila M; Murphy DL
    Biol Psychiatry; 1985 Nov; 20(11):1174-88. PubMed ID: 2413912
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of the orbital cortex and of the serotonergic system in a rat model of obsessive compulsive disorder.
    Joel D; Doljansky J; Roz N; Rehavi M
    Neuroscience; 2005; 130(1):25-36. PubMed ID: 15561422
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enhanced dopamine transporter density in psychotropic-naive patients with obsessive-compulsive disorder shown by [123I]{beta}-CIT SPECT.
    van der Wee NJ; Stevens H; Hardeman JA; Mandl RC; Denys DA; van Megen HJ; Kahn RS; Westenberg HM
    Am J Psychiatry; 2004 Dec; 161(12):2201-6. PubMed ID: 15569890
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neurobiology of obsessive compulsive disorder.
    Insel TR; Winslow JT
    Psychiatr Clin North Am; 1992 Dec; 15(4):813-24. PubMed ID: 1461798
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of fenfluramine on plasma HVA in OCD.
    Hollander E; Stein DJ; Saoud JB; DeCaria CM; Cooper TB; Trungold S; Stanley M; Liebowitz MR
    Psychiatry Res; 1992 May; 42(2):185-8. PubMed ID: 1631253
    [No Abstract]   [Full Text] [Related]  

  • 50. Whole blood serotonin in juvenile obsessive-compulsive disorder.
    Hanna GL; Yuwiler A; Cantwell DP
    Biol Psychiatry; 1991 Apr; 29(8):738-44. PubMed ID: 2054448
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Platelet sulfotransferase in different psychiatric disorders.
    Marazziti D; Palego L; Dell'Osso L; Batistini A; Cassano GB; Akiskal HS
    Psychiatry Res; 1996 Nov; 65(2):73-8. PubMed ID: 9122288
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Genetic factors in obsessive-compulsive disorder: summary of genetic studies].
    Kenézloi E; Nemoda Z
    Psychiatr Hung; 2010; 25(5):378-93. PubMed ID: 21156991
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Early- versus late-onset obsessive-compulsive disorder: investigating genetic and clinical correlates.
    Hemmings SM; Kinnear CJ; Lochner C; Niehaus DJ; Knowles JA; Moolman-Smook JC; Corfield VA; Stein DJ
    Psychiatry Res; 2004 Sep; 128(2):175-82. PubMed ID: 15488960
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cerebrospinal fluid biogenic amine metabolites, plasma-rich platelet serotonin and [3H]imipramine reuptake in the primary fibromyalgia syndrome.
    Legangneux E; Mora JJ; Spreux-Varoquaux O; Thorin I; Herrou M; Alvado G; Gomeni C
    Rheumatology (Oxford); 2001 Mar; 40(3):290-6. PubMed ID: 11285376
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mood-related obsessive-compulsive symptoms in a patient with bipolar affective disorder.
    Gordon A; Rasmussen SA
    J Clin Psychiatry; 1988 Jan; 49(1):27-8. PubMed ID: 3335487
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metergoline blocks the behavioral and neuroendocrine effects of orally administered m-chlorophenylpiperazine in patients with obsessive-compulsive disorder.
    Pigott TA; Zohar J; Hill JL; Bernstein SE; Grover GN; Zohar-Kadouch RC; Murphy DL
    Biol Psychiatry; 1991 Mar; 29(5):418-26. PubMed ID: 2018816
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neurobiology of obsessive compulsive disorder--a serotonergic basis of Freudian repression.
    Katz RJ
    Neurosci Biobehav Rev; 1991; 15(3):375-81. PubMed ID: 1956605
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Critique of reductionistic models of obsessive-compulsive disorder: toward a new explanatory paradigm.
    Franzblau SH; Kanadanian M; Rettig E
    Soc Sci Med; 1995 Jul; 41(1):99-112. PubMed ID: 7667677
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vivo PET study of 5HT(2A) serotonin and D(2) dopamine dysfunction in drug-naive obsessive-compulsive disorder.
    Perani D; Garibotto V; Gorini A; Moresco RM; Henin M; Panzacchi A; Matarrese M; Carpinelli A; Bellodi L; Fazio F
    Neuroimage; 2008 Aug; 42(1):306-14. PubMed ID: 18511303
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serotonergic responsivity in obsessive-compulsive disorder. Effects of chronic clomipramine treatment.
    Zohar J; Insel TR; Zohar-Kadouch RC; Hill JL; Murphy DL
    Arch Gen Psychiatry; 1988 Feb; 45(2):167-72. PubMed ID: 3276283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.